MAPK7 and cancer: These results suggest that the effects observed using IVM and AX15836 in reducing cancer cell proliferation are not due to the overall IVM ability of inhibiting the nuclear translocation of pro‐proliferative factors, but to its ability to prevent ERK5 nuclear shuttling.